New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
180 Life Sciences Corp.
ATNF
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

4M

Biotechnology

Next Earning date - 28 Mar 2025

4M

Biotechnology

Next Earning date - 28 Mar 2025

1.34USD

Shape-0.01 ( -0.74%)
moonAfter-hours 1.35$arrow-right-up0.01 (0.75%)
Market Closed (as of Feb 18, 21:00 EDT)
favorite-chart

Relative Strenght

4
favorite-chart

Volume Buzz

-90%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

92%

Quote Panel

Shape
Updated February 18, 2025
1W -0.74 % 1M -11.84 % 3M -42.98 % 1Y -67.24 %

Key Metrics

Shape
  • Market Cap

    4.26M


  • Shares Outstanding

    3.18M


  • Share in Float

    2.83M


  • Dividende

    0


  • Earning Date

    28 Mar 2025


  • Price Target

    1.34


  • Average Volume

    446620


  • Beta

    0.142


  • Range

    1.16-17.75


  • Industry

    Biotechnology


  • Website

    https://180lifesciences.com


  • Sector

    Healthcare


Fundamentals

Shape

Relative Strength

Shape

ATNF

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$17M

ShapeNaN%

2025-Revenue

$57.00

Shape-6606%

2025-EPS

0

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Price Target

NaN(-100.00%)

Number of analyst

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q2.22

arrow
arrow

N/A

34.22
vs NA

Q3.22

arrow
arrow

N/A

-26.62
vs 87.45

Q4.22

arrow
arrow

N/A

-185.16
vs 11.6

Q1.23

arrow
arrow

N/A

-24.14
vs 1

Q2.23

arrow
arrow

N/A

-13.31
vs 34.22

Q3.23

arrow
arrow

N/A

-2.85
vs -26.62

Q4.23

arrow
arrow

N/A

-1.97
vs -185.16

Q1.24

arrow
arrow

N/A

-1.68
vs -24.14

Q2.24

arrow
arrow

+100%

0.01
vs -13.31

Q3.24

arrow
arrow

N/A

-0.85
vs -2.85

Sales GrowthShape

status-upYoY

Current

Estimates

Q2.22

arrow
arrow

NA

NA  vs NA

Q3.22

arrow
arrow

NA

NA  vs NA

Q4.22

arrow
arrow

NA

NA  vs NA

Q1.23

arrow
arrow

NA

NA  vs NA

Q2.23

arrow
arrow

NA

NA  vs NA

Q3.23

arrow
arrow

NA

NA  vs NA

Q4.23

arrow
arrow

NA

166K  vs NA

Q1.24

arrow
arrow

NA

NA  vs NA

Q2.24

arrow
arrow

NA

NA  vs NA

Q3.24

arrow
arrow

NA

NA  vs NA

Return on EquityShape

status-upQoQ

Q4.22

arrow
arrow

-192%

-1.92
vs -0.82

Q1.23

arrow
arrow

-67%

-0.67
vs -1.92

Q2.23

arrow
arrow

-55%

-0.55
vs -0.67

Q3.23

arrow
arrow

+6875%

68.75
vs -0.55

Q4.23

arrow
arrow

+961%

9.61
vs 68.75

Q1.24

arrow
arrow

+112%

1.12
vs 9.61

Q2.24

arrow
arrow

-3%

-0.03
vs 1.12

Q3.24

arrow
arrow

-22%

-0.22
vs -0.03

Institutionnal OwnershipShape

status-upQoQ

Q4.20

arrow
arrow

9

9
vs NA

NA

Q1.21

arrow
arrow

34

34
vs 9

278%

Q2.21

arrow
arrow

46

46
vs 34

35%

Q3.21

arrow
arrow

41

41
vs 46

-11%

Q4.21

arrow
arrow

48

48
vs 41

17%

Q1.22

arrow
arrow

39

39
vs 48

-19%

Q2.22

arrow
arrow

32

32
vs 39

-18%

Q3.22

arrow
arrow

27

27
vs 32

-16%

Earnings Growth

Latest News